DHEA & Adrenal-Androgen 'Optimization'
The Aging Adrenal Androgen Sold as a Hormone-Optimization Staple
Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Sold OTC as a dietary supplement in the US (post-DSHEA); not FDA-approved as a drug; banned in sport by WADA
Reference only. Not medical advice.
What can go wrong
Because DHEA is converted to androgens and estrogens, it can cause acne, oily skin, hair changes, and in women hirsutism; theoretical concerns exist for hormone-sensitive cancers (prostate, breast). As an OTC supplement it is poorly standardized, with documented content variability. It is prohibited in competitive sport.
This is something to take to a clinician. The Atlas can tell you what is known about dhea & adrenal-androgen 'optimization' in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) are the most abundant circulating steroids, made by the adrenal cortex, and they fall steeply with age ('adrenopause'), dropping ~80% from peak by old age. That decline made DHEA a fixture of anti-aging and hormone-optimization protocols, where it is sold OTC and framed as restoring youthful hormone status. But randomized trials in aging adults have shown, at best, small and inconsistent effects on body composition, bone, libido, and mood, and no convincing benefit on strength, cognition, or 'vitality.' DHEA is a banned substance in sport and can raise downstream estrogen/androgen levels.
An over-the-counter steroid precursor with big promises and thin functional evidence.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
DHEA is a precursor that peripheral tissues convert into testosterone and estradiol via local enzymatic steps. The rationale for supplementation is to restore the youthful pool of substrate. In practice the conversion and clinical translation are modest and variable between individuals (and sexes), which helps explain the inconsistent trial results.
Precursor logic vs trial reality
The 'replace what declines' logic is intuitive but unproven for function. Large RCTs (e.g., the Mayo Clinic 2-year study by Nair et al., NEJM 2006, of DHEA in elderly men and women) found no meaningful improvement in body composition, physical performance, insulin sensitivity, or quality of life. Where signals appear (modest bone or libido effects in some studies), they are small and not consistently replicated. Supplement DHEA also varies widely in actual content.
What has to be monitored
The bloodwork this needs, and the reason it belongs with a clinician rather than a website.
- DHEAS level if used
- Estradiol/testosterone where conversion is a concern
- Lipids and hormone-sensitive cancer surveillance per risk
What people get wrong
Often saidDHEA restores youthful vitality
ActuallyThe largest controlled trials found no meaningful functional, body-composition, or quality-of-life benefit in aging adults. It is a precursor with thin clinical translation.
Often saidIt's just a harmless supplement
ActuallyDHEA is an androgen/estrogen precursor with real hormonal effects, content variability, and a WADA ban; it is not inert.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
At a glance
- What it is
- Adrenal androgen precursor (to T and estradiol)
- Age decline
- ~80% fall from young-adult peak
- US status
- OTC dietary supplement (post-1994 DSHEA)
- WADA
- Prohibited (S1)
- RCT verdict
- Small/inconsistent; no robust functional benefit
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about DHEA & Adrenal-Androgen 'Optimization'. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Nair et al., NEJM (Mayo Clinic DHEA trial)2006
Two years of DHEA (and separately low-dose testosterone) in elderly adults produced no meaningful improvement in body composition, physical performance, insulin action, or quality of life
Various meta-analyses2000s-2010s
Small, inconsistent effects on bone density and libido; no robust functional or cognitive benefit